Shari Damast

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi Marginal recurrences after selective targeting with intensity-modulated radiotherapy for oral tongue cancer
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center MSKCC, New York, New York, USA
    Head Neck 34:900-6. 2012
  2. doi Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 77:1105-12. 2010
  3. doi Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 81:819-26. 2011
  4. doi Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer
    Ana P Kiess
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Gynecol Oncol 127:321-5. 2012
  5. ncbi Do metallic ports in tissue expanders affect postmastectomy radiation delivery?
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 66:305-10. 2006
  6. doi Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 84:e187-93. 2012

Detail Information

Publications6

  1. doi Marginal recurrences after selective targeting with intensity-modulated radiotherapy for oral tongue cancer
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center MSKCC, New York, New York, USA
    Head Neck 34:900-6. 2012
    ..Some centers use intensity-modulated radiotherapy (IMRT) to selectively target only certain regions at risk while sparing others; however, patterns of failure after such selective targeting are rarely reported...
  2. doi Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 77:1105-12. 2010
    ..To assess locoregional outcomes of inflammatory breast cancer (IBC) patients who received standard fractionation radiation with daily skin bolus and taxanes as part of combined-modality therapy (CMT)...
  3. doi Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 81:819-26. 2011
    ..To examine the impact of dose on local failure (LF) rates in the re-treatment of recurrent paraspinal metastases with image-guided intensity-modulated radiotherapy (IG-IMRT)...
  4. doi Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer
    Ana P Kiess
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Gynecol Oncol 127:321-5. 2012
    ..The purpose of this study is to report our single-institution experience with concurrent adjuvant intravaginal radiation (IVRT) and carboplatin/paclitaxel chemotherapy for early stage uterine papillary serous carcinoma (UPSC)...
  5. ncbi Do metallic ports in tissue expanders affect postmastectomy radiation delivery?
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 66:305-10. 2006
    ..Because of concern of potential under-dosing in these patients, we examined the dosimetric effects of the Magna-Site (Santa Barbara, CA) metallic port that is present in certain TEs...
  6. doi Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 84:e187-93. 2012
    ....